Ghosh et al., 2020 - Google Patents
Chemical synthesis and immunological evaluation of entirely carbohydrate conjugate Globo H-PS A1Ghosh et al., 2020
View HTML- Document ID
- 960649613041321870
- Author
- Ghosh S
- Trabbic K
- Shi M
- Nishat S
- Eradi P
- Kleski K
- Andreana P
- Publication year
- Publication venue
- Chemical Science
External Links
Snippet
An anticancer, entirely carbohydrate conjugate, Globo H-polysaccharide A1 (Globo H-PS A1), was chemically prepared and immunologically evaluated in C57BL/6 mice. Tumor associated carbohydrate antigen Globo H hexasaccharide was synthesized in an overall …
- 150000001720 carbohydrates 0 title abstract description 11
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
- A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
- A61K47/4833—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ghosh et al. | Chemical synthesis and immunological evaluation of entirely carbohydrate conjugate Globo H-PS A1 | |
| Shi et al. | Sialyl-Tn polysaccharide A1 as an entirely carbohydrate immunogen: synthesis and immunological evaluation | |
| Compañón et al. | Structure-based design of potent tumor-associated antigens: modulation of peptide presentation by single-atom O/S or O/Se substitutions at the glycosidic linkage | |
| Liao et al. | Fully synthetic self-adjuvanting α-2, 9-oligosialic acid based conjugate vaccines against group C meningitis | |
| Yin et al. | Significant impact of immunogen design on the diversity of antibodies generated by carbohydrate-based anticancer vaccine | |
| AU750701B2 (en) | Alpha-O-linked glycoconjugates, methods of preparation and uses thereof | |
| Zhou et al. | Synthesis and evaluation of GM2-monophosphoryl lipid A conjugate as a fully synthetic self-adjuvant cancer vaccine | |
| US10870710B2 (en) | Synthetic oligosaccharide subunits of the Psl exopolysaccharide of pseudomonas aeruginosa and uses thereof | |
| Chuang et al. | Synthesis and vaccine evaluation of the tumor-associated carbohydrate antigen RM2 from prostate cancer | |
| Allen et al. | A second generation synthesis of the MBr1 (Globo‐H) breast tumor antigen: New application of the N‐pentenyl glycoside method for achieving complex carbohydrate protein linkages | |
| Yin et al. | Chemical synthesis of GM2 glycans, bioconjugation with bacteriophage Qβ, and the induction of anticancer antibodies | |
| JP6143240B2 (en) | Sugar chain immunity inducer | |
| US6544952B1 (en) | Synthesis of glycoconjugates of the globo-H epitope and uses thereof | |
| US20240092932A1 (en) | Monoclonal igm antibodies from entirely carbohydrate constructs | |
| Sorieul et al. | Recent advances and future perspectives on carbohydrate-based cancer vaccines and therapeutics | |
| Guo et al. | Comparative immunological studies of tumor-associated Lewis X, Lewis Y, and KH-1 antigens | |
| AU2012292430B2 (en) | Oligosaccharides and oligosaccharide-protein conjugates derived from Clostridium difficile polysaccaride PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools | |
| Kleski et al. | Synthesis of an aminooxy derivative of the GM3 antigen and its application in oxime ligation | |
| JP2024514683A (en) | Fc glycan remodeling platform method for site-specific antibody conjugation and its applications | |
| Rashidijahanabad et al. | Stereoselective Synthesis of Sialyl Lewisa Antigen and the Effective Anticancer Activity of Its Bacteriophage Qβ Conjugate as an Anticancer Vaccine | |
| Buskas et al. | Synthesis of a dimeric Lewis antigen and the evaluation of the epitope specificity of antibodies elicited in mice | |
| JPWO2016104647A1 (en) | Glycoconjugate vaccine antigen and glycan introduction agent | |
| Bai et al. | A synthetic Tn-BSA conjugate vaccine bearing chitotriose as built-in adjuvant | |
| Chen et al. | Synthesis of azido-globo H analogs for immunogenicity evaluation | |
| Liao et al. | Synthesis and preliminary immunologic properties of di-/trisaccharide-conjugates related to Bacillus anthracis |